Literature DB >> 6261257

Adrenergic regulation of intraocular pressure: identification of beta 2-adrenergic-stimulated adenylate cyclase in ciliary process epithelium.

J A Nathanson.   

Abstract

To determine the site and possible mechanism of action of adrenergic agents in regulating intraocular pressure, experiments were undertaken to identify, localize, and characterize beta-adrenergic receptors associated with adenylate cyclase in various ocular tissues involved in secretion and reabsorption of aqueous humor. The ciliary process epithelium was found to be enriched in an adenylate cyclase with pharmacological characteristics indicative of a predominance of beta 2-adrenergic receptors. The results are consistent with the possibility that the adrenergic nervous system may regulate aqueous humor production through a direct effect on secretion. The data also are relevant to the potential development of drugs that can control increased intraocular pressure.

Mesh:

Substances:

Year:  1980        PMID: 6261257      PMCID: PMC350515          DOI: 10.1073/pnas.77.12.7420

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  In vitro study of beta-adrenergic receptors.

Authors:  B B Wolfe; T K Harden; P B Molinoff
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

2.  A potent new beta2-adrenoceptor blocking agent.

Authors:  J L Imbs; F Miesch; J Schwartz; J Velly; G Leclerc; A Mann; C G Wermuth
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

3.  In vitro determination of the ability of drugs to bind to adrenergic receptors.

Authors:  A H Neufeld; E D Page
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-12       Impact factor: 4.799

4.  Adrenergic sulfonanilides. 4. Centrally active beta-adrenergic agonists.

Authors:  D L Temple; W T Comer; H C Ferguson; L E Allen
Journal:  J Med Chem       Date:  1976-05       Impact factor: 7.446

5.  Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists.

Authors:  E Carlsson; C G Dahlöf; A Hedberg; H Persson; B Tångstrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

6.  Assessment of the selectivity of OPC-2009, a new beta2-adrenoceptor stimulatn, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog.

Authors:  N Himori; N Taira
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

7.  An analysis of selective beta receptor blockade.

Authors:  B Levy; B E Wilkenfeld
Journal:  Eur J Pharmacol       Date:  1969-02       Impact factor: 4.432

8.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

9.  An isotopic assay of cyclic 3',5'-nucleotide phosphodiesterase with aluminum oxide columns.

Authors:  C R Filburn; J Karn
Journal:  Anal Biochem       Date:  1973-04       Impact factor: 3.365

10.  Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs.

Authors:  Y C Clement-Cormier; J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

View more
  18 in total

1.  Atriopeptin, sodium azide and cyclic GMP reduce secretion of aqueous humour and inhibit intracellular calcium release in bovine cultured ciliary epithelium.

Authors:  M Shahidullah; W S Wilson
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 2.  The rush to adrenaline: drugs in sport acting on the beta-adrenergic system.

Authors:  E Davis; R Loiacono; R J Summers
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

3.  beta-Adrenergic receptor subtypes and intraocular pressure.

Authors:  A Rushton
Journal:  Br J Ophthalmol       Date:  1983-08       Impact factor: 4.638

4.  Effects of a potent and specific beta 2-adrenoceptor antagonist on intraocular pressure.

Authors:  J A Nathanson
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

5.  R-enantiomer of timolol: a potential selective ocular antihypertensive agent.

Authors:  N N Share; V J Lotti; P Gautheron; C Schmitt; D M Gross; R A Hall; C A Stone
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

6.  Transformation of human ciliary epithelial cells by simian virus 40: induction of cell proliferation and retention of beta 2-adrenergic receptors.

Authors:  M Coca-Prados; M B Wax
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

7.  Receptor-responses in fresh human ciliary muscle.

Authors:  M D Lograno; A Reibaldi
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

8.  Rational use of the fixed combination of dorzolamide - timolol in the management of raised intraocular pressure and glaucoma.

Authors:  Jason Yeh; Daniel Kravitz; Brian Francis
Journal:  Clin Ophthalmol       Date:  2008-06

9.  Beta-adrenergic receptor subtypes in iris-ciliary body of rabbits.

Authors:  C J Schmitt; D M Gross; N N Share
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

10.  Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues.

Authors:  C Bianchi; J Gutkowska; G Thibault; R Garcia; J Genest; M Cantin
Journal:  Histochemistry       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.